Trading members of the Exchange are hereby informed that the under mentioned new securities of Transgene Biotek Ltd. (Scrip Code: 526139, ISIN No: INE773D01018) are listed and permitted for trading on the Exchange with effect from Monday, November 14, 2005.Securities 60,60,000 * Equity Shares of Rs.10/- each (fully paid-up) issued to shareholders of erstwhile M/s. Saket Bio-technologies Pvt. Ltd. pursuant to Scheme of Amalgamation of the Company. Dist. Nos. 8960001 to 15020000 * These shares are ranking pari-passu with the old equity shares of the company. 2. Trading members may please note that 15,15,000 equity shares of the Company as per details given herein below are non-transferable for 3 years upto November 15, 2008 and therefore these shares would not be good delivery in the market till then. The company has confirmed that the share certificates have been enfaced with a stamp regarding its non-transferability. Distinctive Nos. Number of Shares 8960001 - 9275000 3,15,000 10472001 - 10772000 3,00,000 11684001 - 11984000 3,00,000 12896001 - 13196000 3,00,000 14663399 - 14963398 3,00,000 Total 15,15,000 3. The brief particulars of the Scheme of Amalgamation are as mentioned below: a) The Scheme of Amalgamation of the company was approved by the Hon'ble High Court of Andhra Pradesh vide its order dated February 7, 2005. b)The appointed date: March 31, 2004. c)Date of Allotment: April 27, 2005. d)Exchange Ratio - For every 1 equity shares of Rs.10/- each held in erstwhile M/s. Saket Bio-technologies Pvt. Ltd., 3.03 equity share of Rs.10/- each of the company have been issued. 4. The company's financial year ends on 31st March.